Show simple item record

dc.contributor.authorMatthews, Karen
dc.contributor.authorMacGilchrist, Andrew
dc.contributor.authorSmith, Margaret Coulter
dc.contributor.authorCetnarskyj, Roseanne
dc.date.accessioned2018-06-29T21:36:32Z
dc.date.available2018-06-29T21:36:32Z
dc.date.issued2016-06
dc.identifierER4746
dc.identifier.citationMatthews, K., MacGilchrist, A., Smith, M. & Cetnarskyj, R. (2016) Cirrhosis Screening with a Portable Fibroscan Device in a Community Alcohol Support Service: Feasibility Study, Gut. BMJ.com, vol. 7, , pp. A 291,
dc.identifier.issnISSN: 1468-3288 (online)
dc.identifier.urihttps://eresearch.qmu.ac.uk/handle/20.500.12289/4746
dc.description.abstractAlcohol misuse is the major cause of the increase in deaths from liver disease in the UK,1 particularly in Scotland2 and particularly in areas of social deprivation. Liver disease usually presents late, with advanced liver disease and cirrhosis often asymptomatic.3 Patients with alcohol misuse in areas of social deprivation are a hard to reach- population. This study assessed the feasibility of using a portable Fibroscan to measure transient elastography (TE), a non-invasive method of assessing hepatic fibrosis, as a screening tool within a community alcohol support service.
dc.format.extentA 291
dc.publisherBMJ Publishing Group Ltd
dc.relation.ispartofGut. BMJ.com
dc.titleCirrhosis Screening with a Portable Fibroscan Device in a Community Alcohol Support Service: Feasibility Study
dc.typearticle
dcterms.accessRightspublic
dc.description.facultysch_nur
dc.description.volume7
dc.description.ispublishedpub
dc.description.eprintid4746
rioxxterms.typearticle
refterms.dateAccepted2016-02-27
refterms.dateFCA2018-04-09
refterms.dateFCD2018-04-09
qmu.authorSmith, Margaret Coulter
qmu.centreCentre for Applied Social Sciences
dc.description.statuspub
dc.description.number1


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record